Diabetes Complications: What Adults Should Know

Understanding diabetes complications is one of the most important steps an adult with diabetes can take — not to create fear, but to create motivation and clarity about what is actually at stake in daily diabetes self-management decisions. Many adults with diabetes know that their condition increases the risk of “complications,” but relatively few have a clear picture of what those complications are, which organ systems are affected, how they develop over time, what the warning signs are, and most importantly, what actions reduce the risk most effectively. Diabetes complications are not inevitable — decades of clinical trial evidence show that consistent blood glucose control, blood pressure management, cholesterol treatment, and regular monitoring substantially reduce the risk of developing or progressing through every major complication category. The information in this guide is designed to give adults with diabetes the clinical framework needed to understand what they are protecting against and why the monitoring, medications, and lifestyle work they do every day matters for their long-term health.

Microvascular Complications: Damage to Small Blood Vessels

The microvascular diabetes complications — retinopathy, nephropathy, and neuropathy — are caused by chronic elevated blood glucose damaging the walls of the tiny blood vessels (capillaries and arterioles) that supply the retina, glomeruli of the kidney, and peripheral nerves. These complications are specific to diabetes and are closely tied to the degree and duration of blood glucose elevation:

• Diabetic retinopathy (eye disease): Retinopathy is the most common microvascular complication, affecting approximately 40% of adults with Type 2 diabetes and nearly all adults with Type 1 diabetes of 20 years duration. The retinal capillaries are damaged by hyperglycemia, leading to microaneurysms (small bulges in capillary walls), retinal hemorrhages, hard exudates (lipid deposits), and ultimately new abnormal blood vessel growth (neovascularization) in proliferative diabetic retinopathy — the stage most associated with sudden vision loss. Macular edema (fluid accumulation at the center of the retina) can occur at any stage and directly impairs central vision. Diabetic retinopathy produces no symptoms in early stages; annual dilated eye exams are the only way to detect it before vision loss occurs. The complete retinopathy monitoring guide is our eye exams for people with diabetes article, and the detailed retinopathy guide is our diabetic retinopathy: what to know article.
• Diabetic nephropathy (kidney disease): Nephropathy is the leading cause of chronic kidney disease and kidney failure in developed countries, responsible for approximately 40% of all new dialysis cases. Hyperglycemia damages the glomerular filtration barrier, causing progressive albumin leakage into the urine (detectable with the urine albumin test) and eventual eGFR decline. Early diabetic nephropathy (elevated uACR with normal eGFR) is largely reversible with proper treatment; advanced nephropathy (declining eGFR) represents irreversible nephron loss that can be slowed but not reversed. ACE inhibitors, ARBs, and SGLT2 inhibitors all have proven kidney-protective effects that are most powerful at early disease stages. The kidney monitoring guide is our kidney tests for diabetes monitoring article, and the early warning signs of diabetic kidney disease are covered in our diabetic kidney disease: early warning signs guide.
• Diabetic neuropathy (nerve damage): Neuropathy is the most common diabetes complication, affecting approximately 50% of adults with Type 2 diabetes of long duration. Hyperglycemia damages nerve axons through multiple mechanisms including polyol pathway activation, oxidative stress, and impaired neurotrophic factor production. The most common form — distal symmetric peripheral neuropathy — causes numbness, tingling, burning pain, and loss of protective sensation in the feet and lower legs, progressing proximally over years. Loss of protective sensation is the direct cause of the foot ulcers and infections that lead to the majority of diabetes-related lower-limb amputations. Autonomic neuropathy affects the nerves controlling internal organs, causing gastroparesis (delayed gastric emptying), cardiovascular autonomic neuropathy (resting tachycardia, orthostatic hypotension), and sexual dysfunction. The detailed neuropathy guide is our diabetic neuropathy: symptoms and prevention article.

Macrovascular Complications: Diabetes and Cardiovascular Disease

The macrovascular diabetes complications affect large blood vessels and are the leading causes of death in adults with Type 2 diabetes. Unlike microvascular complications, macrovascular disease is not unique to diabetes — it shares pathophysiology with cardiovascular disease in the general population — but diabetes dramatically accelerates atherosclerosis through multiple mechanisms including hyperglycemia-driven endothelial dysfunction, dyslipidemia, chronic inflammation, and prothrombotic changes:

• Coronary artery disease and heart attack: Adults with diabetes have a two to four times higher risk of coronary artery disease compared to age-matched adults without diabetes. The risk equivalence of diabetes to established cardiovascular disease — meaning that an adult with diabetes but no prior heart attack has a similar 10-year cardiovascular event risk as an adult without diabetes who has already had a heart attack — is the basis for the aggressive cardiovascular risk factor treatment recommended for all adults with diabetes. Heart attacks in adults with diabetes may be “silent” (without typical chest pain) due to cardiac autonomic neuropathy blunting the pain response — making cardiovascular monitoring particularly important. The diabetes and heart attack risk guide is our diabetes and heart attack risk article.
• Stroke: Adults with diabetes have approximately two to four times the risk of ischemic stroke compared to adults without diabetes. Diabetes accelerates atherosclerosis in carotid and cerebral arteries, promotes small vessel disease (lacunar infarcts), and increases thrombotic tendency. Stroke prevention in adults with diabetes relies on the same risk factor management as coronary artery disease prevention — blood pressure control (the most important modifiable stroke risk factor), LDL reduction with statins, antiplatelet therapy in secondary prevention, and blood glucose control. The diabetes and stroke risk guide is our diabetes and stroke risk article.
• Peripheral arterial disease (PAD): PAD — atherosclerosis in the arteries supplying the legs — is two to four times more common in adults with diabetes and tends to involve more distal arterial segments (affecting the tibial and peroneal arteries below the knee, rather than the aorto-iliac and femoral arteries that are more commonly affected in non-diabetic PAD). This distal distribution makes surgical revascularization more technically challenging and contributes to the higher amputation rate in adults with diabetes compared to those without. PAD combined with peripheral neuropathy (loss of protective sensation) and impaired wound healing creates the triad underlying most diabetes-related foot problems — covered in our diabetic foot problems: prevention and care guide. The cholesterol monitoring that reduces PAD and cardiovascular risk is in our cholesterol monitoring in diabetes guide.

How Elevated Blood Glucose Damages Tissues: The Key Mechanisms

Understanding the biological mechanisms through which elevated blood glucose causes diabetes complications helps explain why consistent glucose control is so important and why complications can develop even when blood glucose appears “only slightly elevated” over many years:

• Advanced glycation end-products (AGEs): When glucose is chronically elevated, it reacts non-enzymatically with proteins throughout the body — glycating them and forming advanced glycation end-products. AGEs cross-link with collagen in blood vessel walls, increasing arterial stiffness, thickening the basement membrane of capillaries, and impairing their ability to regulate blood flow. AGEs also bind to specific cell surface receptors (RAGE — receptor for advanced glycation end-products) that activate inflammatory pathways, further damaging endothelial cells and promoting atherosclerosis. The A1C test measures glycated hemoglobin — itself a direct product of this glucose-protein glycation reaction — and its level correlates with the overall glycation burden throughout the body, which is why A1C reduction consistently reduces complication risk across all organ systems. The A1C monitoring that tracks the primary driver of AGE accumulation is in our A1C testing schedule guide.
• Oxidative stress: Hyperglycemia increases mitochondrial production of reactive oxygen species (ROS) — free radicals that damage cell membranes, DNA, and proteins throughout the body. Oxidative stress contributes directly to endothelial dysfunction (impairing the blood vessel’s ability to dilate appropriately and regulate inflammation), promotes low-density lipoprotein oxidation (a critical step in atherosclerotic plaque formation), and damages nerve mitochondria (contributing to axon degeneration in diabetic neuropathy). Antioxidant defense mechanisms are often overwhelmed in chronic hyperglycemia, creating a self-perpetuating cycle of tissue damage.
• Polyol pathway activation (in nerves and retina): In cells that absorb glucose independent of insulin — particularly nerve cells, lens cells, and retinal pericytes — chronic hyperglycemia leads to excess glucose being shunted into the polyol pathway, where it is first converted to sorbitol (by aldose reductase) and then to fructose (by sorbitol dehydrogenase). Sorbitol accumulation causes osmotic stress, reduces intracellular myoinositol (an important second messenger), and consumes NADPH (reducing antioxidant capacity). This mechanism contributes specifically to diabetic neuropathy and cataract formation — the latter being why adults with diabetes develop cataracts at a younger age and higher frequency than adults without diabetes.
• Protein kinase C activation: Hyperglycemia activates protein kinase C (PKC) isoforms through diacylglycerol accumulation. PKC activation increases vascular permeability (contributing to macular edema and albumin leakage into urine), stimulates production of vascular endothelial growth factor (VEGF — the driver of neovascularization in proliferative retinopathy), and promotes inflammatory mediator production. Inhibiting VEGF directly (with anti-VEGF injections into the vitreous) is now the primary treatment for proliferative diabetic retinopathy and diabetic macular edema — targeting the downstream consequence of PKC activation. The comprehensive annual monitoring that tracks complications across all affected organ systems is in our annual diabetes care checklist. The overall diabetes checkup framework is our diabetes checkups: what to expect guide. Authoritative complication information is available from the ADA’s diabetes complications resources, the NIDDK’s diabetes complication prevention information, and the CDC’s diabetes complications overview.

Other Diabetes Complications Adults Should Know About

Beyond the major microvascular and macrovascular complications, adults with diabetes face additional complication categories that receive less public attention but have significant impacts on quality of life, safety, and overall health outcomes:

• Increased susceptibility to infections: Hyperglycemia impairs multiple components of the immune response — neutrophil chemotaxis and phagocytosis (the ability of white blood cells to migrate to and destroy pathogens), complement activity, cellular immunity, and the integrity of physical barriers including skin and mucosal surfaces. This immune impairment means that adults with diabetes develop infections more frequently, experience more severe illness when infected, and have higher rates of hospitalization and complications from infections that are self-limiting in adults without diabetes. Common infections disproportionately affecting adults with diabetes include: urinary tract infections (especially in women), skin and soft tissue infections (cellulitis, necrotizing fasciitis — a surgical emergency that is dramatically more common in people with diabetes), fungal infections (oral and vaginal candidiasis, tinea pedis, onychomycosis), pneumonia (including severe influenza and COVID-19), and tuberculosis. Adults with diabetes should be current on all recommended vaccinations — influenza annually, pneumococcal vaccine per schedule, COVID-19 primary series and updated boosters, hepatitis B series, shingles (Shingrix) vaccine. The diabetes and infections guide is our diabetes and infections article.
• Impaired wound healing: Wound healing in adults with diabetes is impaired at nearly every stage of the process — hemostasis, inflammation, proliferation, and remodeling. Hyperglycemia reduces neutrophil and macrophage function at the wound site, impairs keratinocyte and fibroblast migration and proliferation, reduces collagen synthesis, reduces growth factor production at the wound margin, and impairs angiogenesis (new blood vessel formation needed to supply the healing tissue). The combination of peripheral arterial disease (reduced blood supply to the distal extremities) and impaired immune function creates the conditions for foot ulcers to develop, worsen, and become infected despite superficially minor initial trauma. Approximately 25% of adults with diabetes will develop a foot ulcer in their lifetime, and foot ulcers precede approximately 85% of all diabetes-related amputations. The wound healing complications specific to diabetes are covered in our diabetes and wound healing guide, and foot ulcer prevention is in our diabetic foot problems: prevention and care article.
• Cognitive decline and dementia risk: Adults with Type 2 diabetes have approximately 50–60% higher risk of developing dementia — including both Alzheimer’s disease and vascular dementia — compared to adults without diabetes. The mechanisms are multifactorial: chronic hyperglycemia promotes AGE accumulation in the brain, cerebrovascular disease from hypertension and diabetes reduces cerebral blood flow, recurrent hypoglycemia causes acute neuronal damage, and insulin resistance in the brain may impair the insulin signaling pathways that support synaptic plasticity and amyloid clearance. Dementia risk in adults with diabetes is substantially modified by cardiovascular risk factor control — adults with well-controlled blood glucose, blood pressure, and lipids have significantly lower dementia risk than those with poorly controlled risk factors, paralleling the pattern seen for microvascular complications.
• Depression and diabetes distress: Depression is two to three times more common in adults with diabetes than in the general population — a bidirectional relationship in which depression increases diabetes risk through behavioral mechanisms (inactivity, poor diet, medication non-adherence), while diabetes increases depression risk through biological mechanisms (hypothalamic-pituitary-adrenal axis dysregulation, inflammation) and psychological burden. Diabetes distress — the emotional burden of managing a chronic, progressive disease with complex daily self-management requirements — is distinct from clinical depression but equally important for self-care outcomes. Adults with high diabetes distress have consistently worse blood glucose control, higher medication non-adherence, and lower quality of life than adults with lower distress. Identifying and addressing depression and diabetes distress — through psychotherapy, peer support, medication, and practical burden reduction — is an integral part of comprehensive diabetes care. The complete monitoring framework that addresses all aspects of diabetes care including mental health is in our annual diabetes care checklist and diabetes checkups: what to expect guide. Authoritative complication information is available from the ADA’s complications resources, the NIDDK’s complication prevention guidance, and the CDC’s diabetes complications overview.

The Most Effective Strategies for Preventing Diabetes Complications

The clinical trial evidence on diabetes complication prevention is among the most robust in medicine. Key strategies that have proven effectiveness across multiple large randomized trials include:

• Blood glucose control (A1C below 7.0% for most adults): The UKPDS established that each 1% reduction in A1C reduces microvascular complication risk by approximately 37% in Type 2 diabetes. The DCCT/EDIC similarly demonstrated dramatic microvascular complication reduction with intensive glucose control in Type 1 diabetes. The “metabolic memory” or legacy effect from both trials shows that early, sustained blood glucose control provides lasting complication protection even if control later deteriorates — reinforcing the importance of achieving good control from the earliest point in the disease course. The A1C monitoring that tracks this is in our A1C testing schedule guide.
• Blood pressure control (below 130/80 mmHg): The UKPDS blood pressure arm showed that tight blood pressure control reduced diabetes-related death by 32%, stroke by 44%, and microvascular complications by 37% — with effect sizes comparable to blood glucose control. Blood pressure control is the single most effective intervention for preventing stroke in adults with diabetes and is critically important for slowing diabetic nephropathy progression. The blood pressure monitoring guide is our blood pressure monitoring in diabetes article.
• Cholesterol treatment with statins: The CTT meta-analysis established that statin therapy reduces major cardiovascular events by approximately 22% per 1.0 mmol/L LDL reduction in high-risk adults including those with diabetes. Adults with diabetes aged 40–75 should receive statin therapy regardless of baseline LDL given their elevated cardiovascular risk. Combined with blood glucose and blood pressure control, statin therapy significantly reduces the macrovascular complication burden. The cholesterol monitoring guide is our cholesterol monitoring in diabetes article.
• Regular monitoring — catching complications early when treatment is most effective: Annual dilated eye exams detect retinopathy before vision loss occurs; annual uACR and eGFR testing detect nephropathy when kidney function is still normal; annual foot exams detect neuropathy and peripheral vascular disease before ulcers develop. The complete monitoring schedule that coordinates all of these components is in our annual diabetes care checklist. The diabetes checkups guide that explains what each visit should include is our diabetes checkups: what to expect article. Authoritative prevention guidance is available from the ADA’s complications prevention resources, the NIDDK’s complication prevention information, and the CDC’s diabetes complications overview.

The central message about diabetes complications is that they are not inevitable outcomes that adults with diabetes must simply wait for — they are conditions with well-understood causes and well-established prevention strategies that can substantially reduce their likelihood and slow their progression when implemented early and consistently. Adults who understand what they are protecting against, monitor regularly to detect early damage, and work with their healthcare team to keep blood glucose, blood pressure, and cholesterol within target ranges are taking the most impactful steps available against every major diabetes complication simultaneously. The years of consistent self-management that feel uneventful — the appointments kept, the medications taken, the monitoring done — are the ones that prevent the complications that would otherwise reduce quality of life and shorten life expectancy decades later. In diabetes management, prevention is not passive; it is the most active and consequential thing an adult with diabetes can do.

Sources: American Diabetes Association — Standards of Medical Care in Diabetes, complication screening and prevention recommendations; NIDDK — diabetes complications overview and prevention; CDC — diabetes complication statistics and prevention; UKPDS (UK Prospective Diabetes Study) — blood glucose control and microvascular complication prevention in Type 2 diabetes; DCCT/EDIC — intensive glucose control and complication prevention in Type 1 diabetes; ACCORD, ADVANCE, VADT trials — cardiovascular outcomes with intensive glucose control; metabolic memory (legacy effect) evidence from UKPDS and DCCT/EDIC post-trial monitoring; AGE (advanced glycation end-product) formation mechanism and RAGE receptor-mediated tissue damage; oxidative stress and mitochondrial ROS production in hyperglycemia; polyol pathway activation in diabetic neuropathy and cataract; protein kinase C activation and VEGF-mediated retinal neovascularization; epidemiology of diabetic retinopathy, nephropathy, neuropathy, and cardiovascular disease in Type 2 diabetes populations.